FDA Warning Letter — Custom Compounding Center
The FDA took a Warning Letter action against Custom Compounding Center on March 16, 2016 (Little Rock, AR). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Custom Compounding Center
- Date
- March 16, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Little Rock, AR (United States)